 |
iMDx
Last updated: August 07, 2025
Cavan Redmond (Chairman) and William Annett (CEO)
USA | Funding: $112.3M (+)
Website: https://imdxinc.com
iMDx is focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
Website: https://imdxinc.com
iMDx is focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
